{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,20]],"date-time":"2026-10-20T19:52:07Z","timestamp":1792525927116,"version":"4.5.0"},"reference-count":77,"publisher":"Frontiers Media SA","license":[{"start":{"date-parts":[[2021,3,26]],"date-time":"2021-03-26T00:00:00Z","timestamp":1616716800000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"DOI":"10.13039\/100000002","name":"National Institutes of Health","doi-asserted-by":"publisher","award":["R01-AI-150606"],"award-info":[{"award-number":["R01-AI-150606"]}],"id":[{"id":"10.13039\/100000002","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["frontiersin.org"],"crossmark-restriction":true},"short-container-title":["Front. Immunol."],"abstract":"<jats:p>Cutaneous leishmaniasis exhibits a wide spectrum of clinical presentations from self-resolving infections to severe chronic disease. Anti-parasitic drugs are often ineffective in the most severe forms of the disease, and in some cases the magnitude of the disease can result from an uncontrolled inflammatory response rather than unrestrained parasite replication. In these patients, host-directed therapies offer a novel approach to improve clinical outcome. Importantly, there are many anti-inflammatory drugs with known safety and efficacy profiles that are currently used for other inflammatory diseases and are readily available to be used for leishmaniasis. However, since leishmaniasis consists of a wide range of clinical entities, mediated by a diverse group of leishmanial species, host-directed therapies will need to be tailored for specific types of leishmaniasis. There is now substantial evidence that host-directed therapies are likely to be beneficial beyond autoimmune diseases and cancer and thus should be an important component in the armamentarium to modulate the severity of cutaneous leishmaniasis.<\/jats:p>","DOI":"10.3389\/fimmu.2021.660183","type":"journal-article","created":{"date-parts":[[2021,3,26]],"date-time":"2021-03-26T04:40:46Z","timestamp":1616733646000},"update-policy":"https:\/\/doi.org\/10.3389\/crossmark-policy","source":"Crossref","is-referenced-by-count":53,"title":["Host-Directed Therapies for Cutaneous Leishmaniasis"],"prefix":"10.3389","volume":"12","author":[{"given":"Fernanda O.","family":"Novais","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Camila Farias","family":"Amorim","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Phillip","family":"Scott","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"1965","published-online":{"date-parts":[[2021,3,26]]},"reference":[{"key":"B1","doi-asserted-by":"publisher","DOI":"10.1038\/nri.2016.72","article-title":"Cutaneous leishmaniasis: immune responses in protection and pathogenesis","volume":"16","author":"Scott","year":"2016","journal-title":"Nat Rev Immunol"},{"key":"B2","doi-asserted-by":"publisher","DOI":"10.1038\/nrmicro2608","article-title":"Leishmaniasis: complexity at the host-pathogen interface","volume":"9","author":"Kaye","year":"2011","journal-title":"Nat Rev Microbiol"},{"key":"B3","doi-asserted-by":"publisher","DOI":"10.1093\/infdis\/jiaa374","article-title":"Impaired Th1 response is associated therapeutic failure in patients with cutaneous leishmaniasis caused by Leishmania braziliensis","volume":"223","author":"Carvalho","year":"2020","journal-title":"J Infect Dis"},{"key":"B4","doi-asserted-by":"publisher","DOI":"10.4269\/ajtmh.2009.80.574","article-title":"Association of treatment of American cutaneous leishmaniasis prior to ulcer development with high rate of failure in northeastern Brazil","volume":"80","author":"Unger","year":"2009","journal-title":"Am J Trop Med Hyg"},{"key":"B5","doi-asserted-by":"publisher","first-page":"35","DOI":"10.1038\/nrd.2017.162","article-title":"Host-directed therapies for bacterial and viral infections","volume":"17","author":"Kaufmann","year":"2018","journal-title":"Nat Rev Drug Discovery"},{"key":"B6","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1084\/jem.20192179","article-title":"Understanding adverse events of immunotherapy: A mechanistic perspective","volume":"218","author":"Burke","year":"2021","journal-title":"J Exp Med"},{"key":"B7","doi-asserted-by":"publisher","DOI":"10.1038\/s41571-019-0218-0","article-title":"Adverse effects of immune-checkpoint inhibitors: epidemiology, management and surveillance","volume":"16","author":"Martins","year":"2019","journal-title":"Nat Rev Clin Oncol"},{"key":"B8","doi-asserted-by":"publisher","DOI":"10.1001\/archderm.1965.01600110025007","article-title":"Disseminated cutaneous leishmaniasis; innoculation to laboratory animals, electron microscopy and fluorescent antibodies studies","volume":"91","author":"Convit","year":"1965","journal-title":"Arch Dermatol"},{"key":"B9","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pntd.0007152","article-title":"Host and parasite responses in human diffuse cutaneous leishmaniasis caused by L. amazonensis","volume":"13","author":"Christensen","year":"2019","journal-title":"PloS Negl Trop Dis"},{"key":"B10","doi-asserted-by":"publisher","DOI":"10.1111\/j.1365-4362.1995.tb00613.x","article-title":"Polar and subpolar diffuse cutaneous leishmaniasis in Brazil: clinical and immunopathologic aspects","volume":"34","author":"Barral","year":"1995","journal-title":"Int J Dermatol"},{"key":"B11","doi-asserted-by":"publisher","DOI":"10.3389\/fcimb.2020.00355","article-title":"Tissue damage in human cutaneous leishmaniasis: correlations between inflammatory cells and molecule expression","volume":"10","author":"Saldanha","year":"2020","journal-title":"Front Cell Infect Microbiol"},{"key":"B12","doi-asserted-by":"publisher","DOI":"10.1093\/clinids\/3.3.422","article-title":"The immunology of leprosy: speculations on the leprosy spectrum","volume":"3","author":"Sansonetti","year":"1981","journal-title":"Rev Infect Dis"},{"key":"B13","doi-asserted-by":"publisher","DOI":"10.5935\/0305-7518.19620014","article-title":"A classification of leprosy for research purposes","volume":"33","author":"Ridley","year":"1962","journal-title":"Lepr Rev"},{"key":"B14","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pntd.0009003","article-title":"Risk factors for antimony treatment failure in American Cutaneous Leishmaniasis in Northwestern-Argentina","volume":"15","author":"Garc\u00eda-Bustos","year":"2021","journal-title":"PloS Negl Trop Dis"},{"key":"B15","doi-asserted-by":"publisher","first-page":"189","DOI":"10.1111\/j.1600-065X.1991.tb00611.x","article-title":"Role of cytokines in the differentiation of CD4+ T-cell subsets in vivo","volume":"123","author":"Coffman","year":"1991","journal-title":"Immunol Rev"},{"key":"B16","doi-asserted-by":"publisher","DOI":"10.1016\/S0167-5699(05)80017-9","article-title":"Helper T-cell subsets in mouse leishmaniasis: induction, expansion and effector function","volume":"12","author":"Locksley","year":"1991","journal-title":"Immunol Today"},{"key":"B17","doi-asserted-by":"publisher","DOI":"10.1038\/nri933","article-title":"The immunology of susceptibility and resistance to Leishmania major in mice","volume":"2","author":"Sacks","year":"2002","journal-title":"Nat Rev Immunol"},{"key":"B18","doi-asserted-by":"publisher","DOI":"10.1111\/j.0105-2896.2004.00185.x","article-title":"Re-examination of the immunosuppressive mechanisms mediating non-cure of Leishmania infection in mice","volume":"201","author":"Sacks","year":"2004","journal-title":"Immunol Rev"},{"key":"B19","article-title":"Immunoregulatory pathways in murine leishmaniasis: different regulatory control during Leishmania mexicana mexicana and Leishmania major infections","volume":"61","author":"Alexander","year":"1985","journal-title":"Clin Exp Immunol"},{"key":"B20","doi-asserted-by":"publisher","DOI":"10.1128\/IAI.61.7.2952-2959.1993","article-title":"Immune responses associated with susceptibility of C57BL\/10 mice to Leishmania amazonensis","volume":"61","author":"Afonso","year":"1993","journal-title":"Infect Immun"},{"key":"B21","doi-asserted-by":"publisher","DOI":"10.4049\/jimmunol.174.5.2934","article-title":"Nonhealing infection despite Th1 polarization produced by a strain of Leishmania major in C57BL\/6 mice","volume":"174","author":"Anderson","year":"2005","journal-title":"J Immunol"},{"key":"B22","doi-asserted-by":"publisher","first-page":"897","DOI":"10.1002\/eji.201546015","article-title":"The Nlrp3 inflammasome, IL-1\u03b2, and neutrophil recruitment are required for susceptibility to a nonhealing strain of Leishmania major in C57BL\/6 mice","volume":"46","author":"Charmoy","year":"2016","journal-title":"Eur J Immunol"},{"key":"B23","doi-asserted-by":"publisher","first-page":"94","DOI":"10.1038\/jid.2014.305","article-title":"Genomic profiling of human Leishmania braziliensis lesions identifies transcriptional modules associated with cutaneous immunopathology","volume":"135","author":"Novais","year":"2015","journal-title":"J Invest Dermatol"},{"key":"B24","doi-asserted-by":"publisher","DOI":"10.1371\/journal.ppat.1006349","article-title":"Skin-resident CD4+ T cells protect against Leishmania major by recruiting and activating inflammatory monocytes","volume":"13","author":"Glennie","year":"2017","journal-title":"PloS Pathog"},{"key":"B25","doi-asserted-by":"publisher","first-page":"193","DOI":"10.1186\/s13071-016-1472-y","article-title":"Impact of reactive oxygen species (ROS) on the control of parasite loads and inflammation in Leishmania amazonensis infection","volume":"9","author":"Roma","year":"2016","journal-title":"Parasit Vectors"},{"key":"B26","doi-asserted-by":"publisher","first-page":"196","DOI":"10.4049\/jimmunol.1700899","article-title":"NOX2-Derived Reactive Oxygen Species Control Inflammation during Leishmania amazonensis Infection by Mediating Infection-Induced Neutrophil Apoptosis","volume":"200","author":"Carneiro","year":"2018","journal-title":"J Immunol"},{"key":"B27","doi-asserted-by":"publisher","DOI":"10.1084\/jem.20040172","article-title":"Low dose Leishmania major promotes a transient T helper cell type 2 response that is down-regulated by interferon gamma-producing CD8+ T cells","volume":"199","author":"Uzonna","year":"2004","journal-title":"J Exp Med"},{"key":"B28","doi-asserted-by":"publisher","first-page":"3992","DOI":"10.4049\/jimmunol.168.8.3992","article-title":"CD8+ T cells are required for primary immunity in C57BL\/6 mice following low-dose, intradermal challenge with Leishmania major","volume":"168","author":"Belkaid","year":"2002","journal-title":"J Immunol"},{"key":"B29","doi-asserted-by":"crossref","DOI":"10.4049\/jimmunol.154.10.5320","article-title":"IL-12 is required for natural killer cell activation and subsequent T helper 1 cell development in experimental leishmaniasis","volume":"154","author":"Scharton-Kersten","year":"1995","journal-title":"J Immunol"},{"key":"B30","doi-asserted-by":"publisher","DOI":"10.1084\/jem.20142101","article-title":"Skin-resident memory CD4+ T cells enhance protection against Leishmania major infection","volume":"212","author":"Glennie","year":"2015","journal-title":"J Exp Med"},{"key":"B31","doi-asserted-by":"publisher","DOI":"10.1371\/journal.ppat.1004538","article-title":"Chronic parasitic infection maintains high frequencies of short-lived Ly6C+CD4+ effector T cells that are required for protection against re-infection","volume":"10","author":"Peters","year":"2014","journal-title":"PloS Pathog"},{"key":"B32","doi-asserted-by":"publisher","first-page":"56","DOI":"10.1159\/000246316","article-title":"Successful treatment of cutaneous leishmaniasis using systemic interferon-gamma","volume":"192","author":"Kolde","year":"1996","journal-title":"Dermatol (Basel)"},{"key":"B33","doi-asserted-by":"publisher","DOI":"10.1016\/0035-9203(94)90518-5","article-title":"Clinical healing of antimony-resistant cutaneous or mucocutaneous leishmaniasis following the combined administration of interferon-gamma and pentavalent antimonial compounds","volume":"88","author":"Falcoff","year":"1994","journal-title":"Trans R Soc Trop Med Hyg"},{"key":"B34","doi-asserted-by":"publisher","DOI":"10.1084\/jem.177.5.1505","article-title":"Recombinant interleukin 12 cures mice infected with Leishmania major","volume":"177","author":"Heinzel","year":"1993","journal-title":"J Exp Med"},{"key":"B35","doi-asserted-by":"publisher","DOI":"10.1073\/pnas.92.8.3142","article-title":"Switch from a type 2 to a type 1 T helper cell response and cure of established Leishmania major infection in mice is induced by combined therapy with interleukin 12 and Pentostam","volume":"92","author":"Nabors","year":"1995","journal-title":"Proc Natl Acad Sci USA"},{"key":"B36","doi-asserted-by":"publisher","DOI":"10.1086\/424848","article-title":"Antimony plus recombinant human granulocyte-macrophage colony-stimulating factor applied topically in low doses enhances healing of cutaneous Leishmaniasis ulcers: a randomized, double-blind, placebo-controlled study","volume":"190","author":"Santos","year":"2004","journal-title":"J Infect Dis"},{"key":"B37","doi-asserted-by":"crossref","first-page":"79","DOI":"10.4269\/ajtmh.2005.73.79","article-title":"Successful treatment of refractory cutaneous leishmaniasis with GM-CSF and antimonials","volume":"73","author":"Almeida","year":"2005","journal-title":"Am J Trop Med Hyg"},{"key":"B38","doi-asserted-by":"publisher","DOI":"10.1086\/429238","article-title":"Randomized, double-blind clinical trial of topical imiquimod 5% with parenteral meglumine antimoniate in the treatment of cutaneous leishmaniasis in Peru","volume":"40","author":"Miranda-Ver\u00e1stegui","year":"2005","journal-title":"Clin Infect Dis"},{"key":"B39","doi-asserted-by":"publisher","DOI":"10.1155\/2018\/9014726","article-title":"Pentavalent Antimonials Combined with Other Therapeutic Alternatives for the Treatment of Cutaneous and Mucocutaneous Leishmaniasis: A Systematic Review","volume":"2018","author":"Berbert","year":"2018","journal-title":"Dermatol Res Pract"},{"key":"B40","doi-asserted-by":"publisher","DOI":"10.1093\/infdis\/jir461","article-title":"IL-10 neutralization promotes parasite clearance in splenic aspirate cells from patients with visceral leishmaniasis","volume":"204","author":"Gautam","year":"2011","journal-title":"J Infect Dis"},{"key":"B41","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pntd.0004415","article-title":"Combined immune therapy for the treatment of visceral leishmaniasis","volume":"10","author":"Faleiro","year":"2016","journal-title":"PloS Negl Trop Dis"},{"key":"B42","doi-asserted-by":"publisher","DOI":"10.1126\/science.1636092","article-title":"Transforming growth factor-beta in leishmanial infection: a parasite escape mechanism","volume":"257","author":"Barral-Netto","year":"1992","journal-title":"Science"},{"key":"B43","doi-asserted-by":"publisher","DOI":"10.4049\/jimmunol.0804024","article-title":"IL-27 regulates IL-10 and IL-17 from CD4+ cells in nonhealing Leishmania major infection","volume":"183","author":"Anderson","year":"2009","journal-title":"J Immunol"},{"key":"B44","doi-asserted-by":"publisher","DOI":"10.1038\/s41577-020-0306-5","article-title":"A guide to cancer immunotherapy: from T cell basic science to clinical practice","volume":"20","author":"Waldman","year":"2020","journal-title":"Nat Rev Immunol"},{"key":"B45","doi-asserted-by":"publisher","first-page":"20275","DOI":"10.1038\/s41598-019-56336-8","article-title":"Immunotherapy using anti-PD-1 and anti-PD-L1 in Leishmania amazonensis-infected BALB\/c mice reduce parasite load","volume":"9","author":"da Fonseca-Martins","year":"2019","journal-title":"Sci Rep"},{"key":"B46","doi-asserted-by":"publisher","first-page":"58","DOI":"10.1002\/eji.200535458","article-title":"PD-L1 and PD-L2 have distinct roles in regulating host immunity to cutaneous leishmaniasis","volume":"36","author":"Liang","year":"2006","journal-title":"Eur J Immunol"},{"key":"B47","doi-asserted-by":"publisher","first-page":"1","DOI":"10.3389\/fimmu.2021.632667","article-title":"PD-1 blockade modulates functional activities of exhausted-like T cell in patients with cutaneous leishmaniasis","author":"Garcia De Moura","year":"2021","journal-title":"Front Immunol"},{"key":"B48","doi-asserted-by":"publisher","DOI":"10.1016\/j.cellimm.2020.104196","article-title":"TNF contributes to T-cell exhaustion in chronic L. mexicana infections of mice through PD-L1 up-regulation","volume":"358","author":"Gonz\u00e1lez-Tafoya","year":"2020","journal-title":"Cell Immunol"},{"key":"B49","doi-asserted-by":"publisher","DOI":"10.1086\/511643","article-title":"Oral pentoxifylline combined with pentavalent antimony: a randomized trial for mucosal leishmaniasis","volume":"44","author":"Machado","year":"2007","journal-title":"Clin Infect Dis"},{"key":"B50","doi-asserted-by":"publisher","DOI":"10.4269\/ajtmh.16-0435","article-title":"Oral Pentoxifylline Associated with Pentavalent Antimony: A Randomized Trial for Cutaneous Leishmaniasis","volume":"96","author":"Brito","year":"2017","journal-title":"Am J Trop Med Hyg"},{"key":"B51","doi-asserted-by":"publisher","DOI":"10.4269\/ajtmh.2001.65.87","article-title":"Successful treatment of refractory mucosal leishmaniasis with pentoxifylline plus antimony","volume":"65","author":"Lessa","year":"2001","journal-title":"Am J Trop Med Hyg"},{"key":"B52","doi-asserted-by":"crossref","DOI":"10.4049\/jimmunol.159.9.4467","article-title":"Parasite-driven in vitro human lymphocyte cytotoxicity against autologous infected macrophages from mucosal leishmaniasis","volume":"159","author":"Brodskyn","year":"1997","journal-title":"J Immunol"},{"key":"B53","doi-asserted-by":"publisher","DOI":"10.1111\/j.1365-3024.2009.01125.x","article-title":"Recruitment of CD8(+) T cells expressing granzyme A is associated with lesion progression in human cutaneous leishmaniasis","volume":"31","author":"Faria","year":"2009","journal-title":"Parasite Immunol"},{"key":"B54","doi-asserted-by":"publisher","DOI":"10.1371\/journal.ppat.1003504","article-title":"Cytotoxic T cells mediate pathology and metastasis in cutaneous leishmaniasis","volume":"9","author":"Novais","year":"2013","journal-title":"PloS Pathog"},{"key":"B55","doi-asserted-by":"publisher","DOI":"10.1007\/s00281-015-0475-7","article-title":"CD8+ T cells in cutaneous leishmaniasis: the good, the bad, and the ugly","volume":"37","author":"Novais","year":"2015","journal-title":"Semin Immunopathol"},{"key":"B56","doi-asserted-by":"publisher","DOI":"10.1371\/journal.ppat.1006196","article-title":"CD8+ T cell cytotoxicity mediates pathology in the skin by inflammasome activation and IL-1\u03b2 production","volume":"13","author":"Novais","year":"2017","journal-title":"PloS Pathog"},{"key":"B57","doi-asserted-by":"publisher","DOI":"10.1038\/jid.2013.4","article-title":"CD8(+) granzyme B(+)-mediated tissue injury vs. CD4(+)IFN\u03b3(+)-mediated parasite killing in human cutaneous leishmaniasis","volume":"133","author":"Santos C da","year":"2013","journal-title":"J Invest Dermatol"},{"key":"B58","doi-asserted-by":"publisher","first-page":"898","DOI":"10.1128\/IAI.02404-14","article-title":"Protective and pathological functions of CD8+ T cells in Leishmania braziliensis infection","volume":"83","author":"Cardoso","year":"2015","journal-title":"Infect Immun"},{"key":"B59","doi-asserted-by":"publisher","DOI":"10.1126\/scitranslmed.aax4204","article-title":"Variable gene expression and parasite load predict treatment outcome in cutaneous leishmaniasis","volume":"11","author":"Amorim","year":"2019","journal-title":"Sci Transl Med"},{"key":"B60","doi-asserted-by":"publisher","DOI":"10.1093\/infdis\/jiz538","article-title":"Granzyme B produced by natural killer cells enhances inflammatory response and contributes to the immunopathology of cutaneous leishmaniasis","volume":"221","author":"Campos","year":"2020","journal-title":"J Infect Dis"},{"key":"B61","doi-asserted-by":"publisher","DOI":"10.1111\/imm.13173","article-title":"Compartmentalized cytotoxic immune response leads to distinct pathogenic roles of natural killer and senescent CD8+ T cells in human cutaneous leishmaniasis","volume":"159","author":"Covre","year":"2020","journal-title":"Immunology"},{"key":"B62","doi-asserted-by":"publisher","DOI":"10.4049\/jimmunol.1701597","article-title":"CD8+ T Cells Lack Local Signals To Produce IFN-\u03b3 in the Skin during Leishmania Infection","volume":"200","author":"Novais","year":"2018","journal-title":"J Immunol"},{"key":"B63","doi-asserted-by":"crossref","DOI":"10.4049\/jimmunol.158.11.5374","article-title":"Role of CD4+ T cells in pathogenesis associated with Leishmania amazonensis infection","volume":"158","author":"Soong","year":"1997","journal-title":"J Immunol"},{"key":"B64","doi-asserted-by":"publisher","DOI":"10.1371\/journal.ppat.1003970","article-title":"Engagement of NKG2D on bystander memory CD8 T cells promotes increased immunopathology following Leishmania major infection","volume":"10","author":"Crosby","year":"2014","journal-title":"PloS Pathog"},{"key":"B65","doi-asserted-by":"publisher","DOI":"10.4049\/jimmunol.1500855","article-title":"Lymphocytic Choriomeningitis Virus Expands a Population of NKG2D+CD8+ T Cells That Exacerbates Disease in Mice Coinfected with Leishmania major","volume":"195","author":"Crosby","year":"2015","journal-title":"J Immunol"},{"key":"B66","doi-asserted-by":"publisher","DOI":"10.1038\/jid.2009.428","article-title":"T cells specific to leishmania and other nonrelated microbial antigens can migrate to human leishmaniasis skin lesions","volume":"130","author":"Da-Cruz","year":"2010","journal-title":"J Invest Dermatol"},{"key":"B67","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pntd.0004992","article-title":"Meta-transcriptome Profiling of the Human-Leishmania braziliensis Cutaneous Lesion","volume":"10","author":"Christensen","year":"2016","journal-title":"PloS Negl Trop Dis"},{"key":"B68","doi-asserted-by":"publisher","DOI":"10.1128\/IAI.00499-07","article-title":"Role of interleukin-1beta in activating the CD11c(high) CD45RB- dendritic cell subset and priming Leishmania amazonensis-specific CD4+ T cells in vitro and in vivo","volume":"75","author":"Xin","year":"2007","journal-title":"Infect Immun"},{"key":"B69","doi-asserted-by":"publisher","DOI":"10.1093\/intimm\/dxq006","article-title":"IL-1-induced inflammation promotes development of leishmaniasis in susceptible BALB\/c mice","volume":"22","author":"Voronov","year":"2010","journal-title":"Int Immunol"},{"key":"B70","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pntd.0001533","article-title":"Disease severity in patients infected with Leishmania mexicana relates to IL-1\u03b2","volume":"6","author":"Fern\u00e1ndez-Figueroa","year":"2012","journal-title":"PloS Negl Trop Dis"},{"key":"B71","doi-asserted-by":"publisher","DOI":"10.1038\/jid.2011.99","article-title":"A role for leukocyte-derived IL-1RA in DC homeostasis revealed by increased susceptibility of IL-1RA-deficient mice to cutaneous leishmaniasis","volume":"131","author":"Kautz-Neu","year":"2011","journal-title":"J Invest Dermatol"},{"key":"B72","doi-asserted-by":"publisher","DOI":"10.1038\/nm.3221","article-title":"Inflammasome-derived IL-1\u03b2 production induces nitric oxide-mediated resistance to Leishmania","volume":"19","author":"Lima-Junior","year":"2013","journal-title":"Nat Med"},{"key":"B73","doi-asserted-by":"publisher","DOI":"10.1038\/nrd.2017.201","article-title":"JAK inhibition as a therapeutic strategy for immune and inflammatory diseases","volume":"16","author":"Schwartz","year":"2017","journal-title":"Nat Rev Drug Discovery"},{"key":"B74","doi-asserted-by":"publisher","DOI":"10.1038\/nm.3645","article-title":"Alopecia areata is driven by cytotoxic T lymphocytes and is reversed by JAK inhibition","volume":"20","author":"Xing","year":"2014","journal-title":"Nat Med"},{"key":"B75","doi-asserted-by":"publisher","DOI":"10.1016\/j.jid.2020.07.011","article-title":"Granzyme B inhibition by tofacitinib blocks the pathology induced by CD8 T cells in cutaneous leishmaniasis","volume":"141","author":"Novais","year":"2020","journal-title":"J Invest Dermatol"},{"key":"B76","doi-asserted-by":"publisher","DOI":"10.1126\/science.1225152","article-title":"Compartmentalized control of skin immunity by resident commensals","volume":"337","author":"Naik","year":"2012","journal-title":"Science"},{"key":"B77","doi-asserted-by":"publisher","first-page":"13","DOI":"10.1016\/j.chom.2017.06.006","article-title":"Cutaneous Leishmaniasis Induces a Transmissible Dysbiotic Skin Microbiota that Promotes Skin Inflammation","volume":"22","author":"Gimblet","year":"2017","journal-title":"Cell Host Microbe"}],"container-title":["Frontiers in Immunology"],"original-title":[],"link":[{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/fimmu.2021.660183\/full","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,10,24]],"date-time":"2023-10-24T01:21:19Z","timestamp":1698110479000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/fimmu.2021.660183\/full"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2021,3,26]]},"references-count":77,"alternative-id":["10.3389\/fimmu.2021.660183"],"URL":"https:\/\/doi.org\/10.3389\/fimmu.2021.660183","relation":{},"ISSN":["1664-3224"],"issn-type":[{"value":"1664-3224","type":"electronic"}],"subject":[],"published":{"date-parts":[[2021,3,26]]},"article-number":"660183"}}